Marko Oblak

872 total citations
16 papers, 730 citations indexed

About

Marko Oblak is a scholar working on Molecular Biology, Organic Chemistry and Toxicology. According to data from OpenAlex, Marko Oblak has authored 16 papers receiving a total of 730 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Organic Chemistry and 4 papers in Toxicology. Recurrent topics in Marko Oblak's work include Cancer therapeutics and mechanisms (5 papers), Bioactive Compounds and Antitumor Agents (4 papers) and Synthesis and biological activity (3 papers). Marko Oblak is often cited by papers focused on Cancer therapeutics and mechanisms (5 papers), Bioactive Compounds and Antitumor Agents (4 papers) and Synthesis and biological activity (3 papers). Marko Oblak collaborates with scholars based in Slovenia, France and Serbia. Marko Oblak's co-authors include Tomaž Šolmajer, Tom Šolmajer, Roman Jerala, Miha Kotnik, Andreja Plaper, Milan Randić, U. Urleb, Simona Golič Grdadolnik, Katja Kristan and Matjaž Brvar and has published in prestigious journals such as Journal of Molecular Biology, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Marko Oblak

16 papers receiving 705 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marko Oblak Slovenia	10	395	196	115	104	97	16	730
Juan Guzman United Kingdom	19	486 1.2×	321 1.6×	63 0.5×	193 1.9×	196 2.0×	38	1.2k
Arvind S. Negi India	14	407 1.0×	190 1.0×	63 0.5×	203 2.0×	82 0.8×	31	816
Varomyalin Tipmanee Thailand	17	335 0.8×	90 0.5×	91 0.8×	73 0.7×	96 1.0×	48	761
Amit Nargotra India	22	641 1.6×	326 1.7×	175 1.5×	118 1.1×	84 0.9×	54	1.2k
Thanh‐Dao Tran Vietnam	18	325 0.8×	349 1.8×	51 0.4×	112 1.1×	56 0.6×	52	926
Attilio Di Pietro France	12	571 1.4×	98 0.5×	82 0.7×	110 1.1×	20 0.2×	13	1.0k
Nitin Pal Kalia India	18	649 1.6×	277 1.4×	253 2.2×	73 0.7×	123 1.3×	67	1.3k
Milan Mladenović Serbia	19	319 0.8×	292 1.5×	27 0.2×	265 2.5×	120 1.2×	45	977
Ahmad J. Almalki Saudi Arabia	16	313 0.8×	173 0.9×	62 0.5×	41 0.4×	65 0.7×	32	707

Countries citing papers authored by Marko Oblak

Since Specialization

Citations

This map shows the geographic impact of Marko Oblak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marko Oblak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marko Oblak more than expected).

Fields of papers citing papers by Marko Oblak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marko Oblak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marko Oblak. The network helps show where Marko Oblak may publish in the future.

Co-authorship network of co-authors of Marko Oblak

This figure shows the co-authorship network connecting the top 25 collaborators of Marko Oblak. A scholar is included among the top collaborators of Marko Oblak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marko Oblak. Marko Oblak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Brvar, Matjaž, Andrej Perdih, Marko Oblak, Lucíja Peterlin Mašič, & Tom Šolmajer. (2009). In silico discovery of 2-amino-4-(2,4-dihydroxyphenyl)thiazoles as novel inhibitors of DNA gyrase B. Bioorganic & Medicinal Chemistry Letters. 20(3). 958–962. 52 indexed citations

Kristan, Katja, Miha Kotnik, Marko Oblak, & U. Urleb. (2009). New High-Throughput Fluorimetric Assay for Discovering Inhibitors of UDP-N-Acetylmuramyl-l-Alanine: d-Glutamate (MurD) Ligase. SLAS DISCOVERY. 14(4). 412–418. 12 indexed citations

Stanovnik, Branko, Uroš Grošelj, Anton Meden, et al.. (2008). Synthesis of 8-Hydroxyimidazo[1,2-a]pyridine-2-carboxylic Acid and Its Derivatives. Heterocycles. 75(6). 1355–1355. 7 indexed citations

Kotnik, Miha, Carlos Contreras‐Martel, Marko Oblak, et al.. (2007). Structural and Functional Characterization of Enantiomeric Glutamic Acid Derivatives as Potential Transition State Analogue Inhibitors of MurD Ligase. Journal of Molecular Biology. 370(1). 107–115. 81 indexed citations

Oblak, Marko, Miha Kotnik, & Tom Šolmajer. (2007). Discovery and Development of ATPase Inhibitors of DNA Gyrase as Antibacterial Agents. Current Medicinal Chemistry. 14(19). 2033–2047. 100 indexed citations

Selič, Lovro, Marko Anderluh, Marko Oblak, et al.. (2007). 4-Substituted Trinems as Broad Spectrum β-Lactamase Inhibitors: Structure-Based Design, Synthesis, and Biological Activity. Journal of Medicinal Chemistry. 50(17). 4113–4121. 25 indexed citations

Zega, Anamarija, Aleš Obreza, Marko Oblak, et al.. (2006). Direct thrombin inhibitors built on the azaphenylalanine scaffold provoke degranulation of mast cells. Thrombosis and Haemostasis. 95(2). 294–300. 4 indexed citations

Mlinšek, Gregor, Marko Oblak, Milan Hodošček, & Tom Šolmajer. (2006). Thrombin inhibitors with novel P1 binding pocket functionality: free energy of binding analysis. Journal of Molecular Modeling. 13(1). 247–254. 3 indexed citations

Oblak, Marko, Simona Golič Grdadolnik, Miha Kotnik, et al.. (2006). Biophysical characterization of an indolinone inhibitor in the ATP-binding site of DNA gyrase. Biochemical and Biophysical Research Communications. 349(4). 1206–1213. 11 indexed citations

10.

Oblak, Marko, et al.. (2005). In silico fragment-based discovery of indolin-2-one analogues as potent DNA gyrase inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(23). 5207–5210. 62 indexed citations

11.

Erić, Slavica, Tomaž Šolmajer, Jure Zupan, et al.. (2004). Prediction of selectivity of α1-adrenergic antagonists by counterpropagation neural network (CP-ANN). Il Farmaco. 59(5). 389–395. 5 indexed citations

12.

Erić, Slavica, Tomaž Šolmajer, Jure Zupan, et al.. (2004). Quantitative structure?activity relationships of a 1 adrenergic antagonists. Journal of Molecular Modeling. 10(2). 139–150. 6 indexed citations

13.

Oblak, Marko, et al.. (2004). Thiol-reactive Clenbuterol Analogues Conjugated to Bovine Serum Albumin. Zeitschrift für Naturforschung C. 59(11-12). 880–886. 9 indexed citations

14.

Kotnik, Miha, et al.. (2004). Quantitative Structure‐Activity Relationships of Streptococcus pneumoniae MurD Transition State Analogue Inhibitors. QSAR & Combinatorial Science. 23(6). 399–405. 7 indexed citations

15.

Plaper, Andreja, et al.. (2003). Characterization of quercetin binding site on DNA gyrase. Biochemical and Biophysical Research Communications. 306(2). 530–536. 288 indexed citations

16.

Oblak, Marko, Milan Randić, & Tomaž Šolmajer. (2000). Quantitative Structure−Activity Relationship of Flavonoid Analogues. 3. Inhibition of p56^lck Protein Tyrosine Kinase. Journal of Chemical Information and Computer Sciences. 40(4). 994–1001. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact